Defining targets of modulation of human tumor cell response to cisplatin

Giovanni Luca Beretta, Laura Gatti, Elisabetta Corna, Nives Carenini, Franco Zunino, Paola Perego

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We previously observed that in yeast cisplatin activates different pathways accounting for stress response. Here, we investigated whether genes involved in yeast drug response were modulated by cisplatin in human tumor cell lines (A2780, IGROV-1, A431, U2-OS) including cisplatin-resistant sublines (A2780/BBR, IGROV-1/Pt1, A431/Pt and U2-OS/Pt). Factors and pathways involved in stress response (glutathione-S-transferase, proteasome, checkpoint control and recombinational repair) were increased by cisplatin in human tumor sensitive and resistant cells. Moreover, sensitization to cisplatin by pharmacologically targeting glutathione or proteasome was observed in sensitive and resistant cells. Interestingly, only in IGROV-1/Pt1 cells, in which cisplatin up-regulated HSP70 and HSP90, targeting of HSP90 resulted in sensitization of resistant cells, suggesting a protective role of stress response. In conclusion, the present findings support the potential relevance of interfering with heat shock protein response to increase cisplatin cytotoxicity in resistant cells. Overall, pathways activated by cisplatin in human tumor cells appear cell-type specific, at least in part reflecting the stress response observed in yeast.

Original languageEnglish
Pages (from-to)1406-1415
Number of pages10
JournalJournal of Inorganic Biochemistry
Volume102
Issue number7
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Cisplatin
Tumors
Cells
Modulation
Neoplasms
Yeast
Yeasts
Proteasome Endopeptidase Complex
Heat-Shock Response
Cytotoxicity
Heat-Shock Proteins
Glutathione Transferase
Tumor Cell Line
Glutathione
Repair
Genes
Pharmaceutical Preparations

Keywords

  • Cisplatin
  • Human tumor cells
  • Modulation
  • Resistance
  • Stress response

ASJC Scopus subject areas

  • Biochemistry
  • Inorganic Chemistry

Cite this

Defining targets of modulation of human tumor cell response to cisplatin. / Beretta, Giovanni Luca; Gatti, Laura; Corna, Elisabetta; Carenini, Nives; Zunino, Franco; Perego, Paola.

In: Journal of Inorganic Biochemistry, Vol. 102, No. 7, 07.2008, p. 1406-1415.

Research output: Contribution to journalArticle

Beretta, Giovanni Luca ; Gatti, Laura ; Corna, Elisabetta ; Carenini, Nives ; Zunino, Franco ; Perego, Paola. / Defining targets of modulation of human tumor cell response to cisplatin. In: Journal of Inorganic Biochemistry. 2008 ; Vol. 102, No. 7. pp. 1406-1415.
@article{6e890b840b9b4616ab011dcfe15b6869,
title = "Defining targets of modulation of human tumor cell response to cisplatin",
abstract = "We previously observed that in yeast cisplatin activates different pathways accounting for stress response. Here, we investigated whether genes involved in yeast drug response were modulated by cisplatin in human tumor cell lines (A2780, IGROV-1, A431, U2-OS) including cisplatin-resistant sublines (A2780/BBR, IGROV-1/Pt1, A431/Pt and U2-OS/Pt). Factors and pathways involved in stress response (glutathione-S-transferase, proteasome, checkpoint control and recombinational repair) were increased by cisplatin in human tumor sensitive and resistant cells. Moreover, sensitization to cisplatin by pharmacologically targeting glutathione or proteasome was observed in sensitive and resistant cells. Interestingly, only in IGROV-1/Pt1 cells, in which cisplatin up-regulated HSP70 and HSP90, targeting of HSP90 resulted in sensitization of resistant cells, suggesting a protective role of stress response. In conclusion, the present findings support the potential relevance of interfering with heat shock protein response to increase cisplatin cytotoxicity in resistant cells. Overall, pathways activated by cisplatin in human tumor cells appear cell-type specific, at least in part reflecting the stress response observed in yeast.",
keywords = "Cisplatin, Human tumor cells, Modulation, Resistance, Stress response",
author = "Beretta, {Giovanni Luca} and Laura Gatti and Elisabetta Corna and Nives Carenini and Franco Zunino and Paola Perego",
year = "2008",
month = "7",
doi = "10.1016/j.jinorgbio.2008.01.002",
language = "English",
volume = "102",
pages = "1406--1415",
journal = "Journal of Inorganic Biochemistry",
issn = "0162-0134",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Defining targets of modulation of human tumor cell response to cisplatin

AU - Beretta, Giovanni Luca

AU - Gatti, Laura

AU - Corna, Elisabetta

AU - Carenini, Nives

AU - Zunino, Franco

AU - Perego, Paola

PY - 2008/7

Y1 - 2008/7

N2 - We previously observed that in yeast cisplatin activates different pathways accounting for stress response. Here, we investigated whether genes involved in yeast drug response were modulated by cisplatin in human tumor cell lines (A2780, IGROV-1, A431, U2-OS) including cisplatin-resistant sublines (A2780/BBR, IGROV-1/Pt1, A431/Pt and U2-OS/Pt). Factors and pathways involved in stress response (glutathione-S-transferase, proteasome, checkpoint control and recombinational repair) were increased by cisplatin in human tumor sensitive and resistant cells. Moreover, sensitization to cisplatin by pharmacologically targeting glutathione or proteasome was observed in sensitive and resistant cells. Interestingly, only in IGROV-1/Pt1 cells, in which cisplatin up-regulated HSP70 and HSP90, targeting of HSP90 resulted in sensitization of resistant cells, suggesting a protective role of stress response. In conclusion, the present findings support the potential relevance of interfering with heat shock protein response to increase cisplatin cytotoxicity in resistant cells. Overall, pathways activated by cisplatin in human tumor cells appear cell-type specific, at least in part reflecting the stress response observed in yeast.

AB - We previously observed that in yeast cisplatin activates different pathways accounting for stress response. Here, we investigated whether genes involved in yeast drug response were modulated by cisplatin in human tumor cell lines (A2780, IGROV-1, A431, U2-OS) including cisplatin-resistant sublines (A2780/BBR, IGROV-1/Pt1, A431/Pt and U2-OS/Pt). Factors and pathways involved in stress response (glutathione-S-transferase, proteasome, checkpoint control and recombinational repair) were increased by cisplatin in human tumor sensitive and resistant cells. Moreover, sensitization to cisplatin by pharmacologically targeting glutathione or proteasome was observed in sensitive and resistant cells. Interestingly, only in IGROV-1/Pt1 cells, in which cisplatin up-regulated HSP70 and HSP90, targeting of HSP90 resulted in sensitization of resistant cells, suggesting a protective role of stress response. In conclusion, the present findings support the potential relevance of interfering with heat shock protein response to increase cisplatin cytotoxicity in resistant cells. Overall, pathways activated by cisplatin in human tumor cells appear cell-type specific, at least in part reflecting the stress response observed in yeast.

KW - Cisplatin

KW - Human tumor cells

KW - Modulation

KW - Resistance

KW - Stress response

UR - http://www.scopus.com/inward/record.url?scp=44649103370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649103370&partnerID=8YFLogxK

U2 - 10.1016/j.jinorgbio.2008.01.002

DO - 10.1016/j.jinorgbio.2008.01.002

M3 - Article

VL - 102

SP - 1406

EP - 1415

JO - Journal of Inorganic Biochemistry

JF - Journal of Inorganic Biochemistry

SN - 0162-0134

IS - 7

ER -